The Peptide Pivot: What's Behind Hims' Stock Volatility? Hims & Hers Health (HIMS) stock has been volatile of late, plummeting despite beating sales estimates.
The company's shares recovered partially by day's end, but the underlying factors driving this volatility are complex. A Peptide Pioneer in the Making?
The FDA's advisors have cleared the way for compounding pharmacies to produce six previously banned peptides, a move that has sent shockwaves through the industry.